Clindamycin Phosphate For Injection

【Physical Description】
      White to off-white, porous cake or powder
【Therapeutic Indications】
"Clindamycin is indicated in the treatment of serious infections caused by susceptible strains of the designated organisms in the conditions listed below:
 Lower respiratory tract infections including pneumonia, empyema, and lung abscess caused by anaerobes, Streptococcus pneumoniae, other streptococci (except E. faecalis), and Staphylococcusaureus.
 Skin and skin structure infections caused by Streptococcus pyogenes, Staphylococcus aureus, and anaerobes.
 Gynecological infections including endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection caused by susceptible anaerobes.
 Intra-abdominal infections including peritonitis and intra-abdominal abscess caused by susceptible anaerobic organisms.
 Septicemia caused by Staphylococcus aureus, streptococci (except Enterococcus faecalis), and susceptible anaerobes.
 Bone and joint infections including acute hematogenous osteomyelitis caused by Staphylococcus aureus and as adjunctive therapy in the surgical treatment of chronic bone and joint infections due to susceptible organisms.
 To reduce the development of drug-resistant bacteria and maintain the effectiveness of clindamycin and other antibacterial drugs, clindamycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy."
【CFDA number】

菠菜开户